Lumos Diagnostics Holdings Limited (FRA:7YU)

Germany · Delayed Price · Currency is EUR

0.0515

0.00 (0.00%)

Last updated: Aug 26, 2026, 8:08 AM CET

-53.65% (1Y)

Market Cap	60.79M +52.0%
Revenue (ttm)	11.55M -16.7%
Net Income	-4.33M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0515
Previous Close	0.0515
Day's Range	0.0515 - 0.0515
52-Week Range	0.0385 - 0.1780
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About FRA:7YU

Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platfor... [Read more]

Industry Measuring and Controlling Devices, not elsewhere classified

Founded 2018

Country Australia

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 7YU

Financial Performance

In fiscal year 2025, FRA:7YU's revenue was $12.40 million, an increase of 11.40% compared to the previous year's $11.13 million. Losses were -$7.18 million, -16.40% less than in 2024.

Financial numbers in USD Financial Statements